Product Information
SM URINARY PAIN RLF 99.5 MG TB is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1730 per EA under NDC 70677007801. Its NADAC has been published 229 times since May 19, 2021.
Strength
99.5 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677007801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
PHENAZOPYRIDINE HYDROCHLORIDEApproval Type
Unapproved
On Market Since
9/12/2019
Price Statistics
The NADAC for SM URINARY PAIN RLF 99.5 MG TB has been published 229 times since May 19, 2021, and over the history we have for it it has risen 14.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1730 per EA |
|---|---|
| All-time high | $0.2052 (Sep 11, 2024) |
| All-time low | $0.1500 (Nov 17, 2021) |
| Median price | $0.1815 |
| Average price | $0.1790 |
| Largest weekly change | +16.1% (Aug 21, 2024) |
| Weeks tracked | 229 |
| Tracking since | May 19, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-7.5%
5Y
+14.8%
All
+14.9%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PHENAZOPYRIDINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SM URINARY PAIN RLF 99.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for SM URINARY PAIN RLF 99.5 MG TB, manufactured by Strategic Sourcing Services LLC, is $0.1730 per EA (NDC 70677007801), effective Oct 1, 2025.
How has the price of SM URINARY PAIN RLF 99.5 MG TB changed over time?
Over the history we have for it, the NADAC for SM URINARY PAIN RLF 99.5 MG TB has risen 14.9%. It has been tracked across 229 weekly CMS publications since May 19, 2021.
What are the highest and lowest recorded NADAC prices for SM URINARY PAIN RLF 99.5 MG TB?
Since May 19, 2021, the NADAC for SM URINARY PAIN RLF 99.5 MG TB has ranged from a low of $0.1500 (Nov 17, 2021) to a high of $0.2052 (Sep 11, 2024), with a median of $0.1815 per EA.
Are there cheaper alternatives to SM URINARY PAIN RLF 99.5 MG TB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SM URINARY PAIN RLF 99.5 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures SM URINARY PAIN RLF 99.5 MG TB?
SM URINARY PAIN RLF 99.5 MG TB (NDC 70677007801) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.